| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Zymeworks Inc (NYSE: ZYME)
ZYME Technical Analysis
5
| As on 25th Jan 2022 ZYME Share Price closed @ 10.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 38.47 & Strong Sell for SHORT-TERM with Stoploss of 45.94 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ZYME Share Price
| Open | 9.89 | Change | Price | % |
| High | 10.32 | 1 Day | 0.01 | 0.10 |
| Low | 9.54 | 1 Week | -4.55 | -31.25 |
| Close | 10.01 | 1 Month | -6.06 | -37.71 |
| Volume | 515463 | 1 Year | -33.33 | -76.90 |
| 52 Week High 56.81 | 52 Week Low 10.00 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| F | 19.98 | -2.01% |
| BACA-U | 302.00 | 0.67% |
| T | 26.48 | 0.53% |
| BAC | 45.43 | 1.98% |
| BBD | 4.05 | 4.65% |
| RPAI | 13.15 | -3.17% |
| NIO | 23.79 | -4.34% |
| PBR | 13.16 | 4.11% |
| PLTR | 13.06 | -2.54% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| ZYME Daily Charts |
ZYME Intraday Charts |
Whats New @ Bazaartrend |
ZYME Free Analysis |
|
|
ZYME Important Levels Intraday
| RESISTANCE | 11.51 |
| RESISTANCE | 11.03 |
| RESISTANCE | 10.73 |
| RESISTANCE | 10.44 |
| SUPPORT | 9.58 |
| SUPPORT | 9.29 |
| SUPPORT | 8.99 |
| SUPPORT | 8.51 |
ZYME Target for Month January
| 4th UP TARGET | 42.83 |
| 3rd UP TARGET | 32.3 |
| 2nd UP TARGET | 25.8 |
| 1st UP TARGET | 19.29 |
| 1st DOWN TARGET | 0.73 |
| 2nd DOWN TARGET | -5.78 |
| 3rd DOWN TARGET | -12.28 |
| 4th DOWN TARGET | -22.81 |
ZYME Weekly Target
| 4th UP TARGET | 18.01 |
| 3rd UP TARGET | 15.44 |
| 2nd UP TARGET | 13.86 |
| 1st UP TARGET | 12.27 |
| 1st DOWN TARGET | 7.75 |
| 2nd DOWN TARGET | 6.16 |
| 3rd DOWN TARGET | 4.58 |
| 4th DOWN TARGET | 2.01 |
ZYME Target for Year 2022
| 4th UP TARGET | 105.57 |
| 3rd UP TARGET | 74.92 |
| 2nd UP TARGET | 55.98 |
| 1st UP TARGET | 37.04 |
| 1st DOWN TARGET | -17.02 |
| 2nd DOWN TARGET | -35.96 |
| 3rd DOWN TARGET | -54.9 |
| 4th DOWN TARGET | -85.55 |
Zymeworks Inc ( NYSE USA Symbol : ZYME )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ZYME Business Profile
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, and breast cancer; and ZW49, a biparatopic anti- human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; and BeiGene, Ltd. It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was founded in 2003 and is headquartered in Vancouver, Canada. Address: 1385 West 8th Avenue, Vancouver, BC, Canada, V6H 3V9
© 2005-2021 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service